Both medications contain the same active ingredient, semaglutide GLP-1, which mimics the GLP-1 hormone to help regulate appetite, increase satiety, and reduce food intake, ultimately aiding in weight loss
So before I hog all the credit here, uh hello everyone
At SynergenX, PT-141 is offered as part of a personalized, provider-guided treatment plan for women experiencing low libido, reduced arousal, or changes in sexual health
Just one day before the patent fell in India, Novo Nordisk received US FDA approval for a higher-dose version of Wegovy Wegovy HD, with its higher dose and superior clinical data, was FDA-approved the day before the patent fell, and 49 downstream patents protect its delivery systems through 2042